Navigation Links
MSA Declares Fourth Quarter Dividend
Date:11/5/2008

PITTSBURGH, Nov. 5 /PRNewswire-FirstCall/ -- The Board of Directors of MSA (NYSE: MSA) today declared a fourth quarter dividend of 24 cents per share on common stock, payable December 10, 2008 to shareholders of record on November 17, 2008.

The Board also declared a dividend of 56-1/4 cents per share on preferred stock, payable December 1, 2008 to shareholders of record on November 17, 2008.

About MSA:

Established in 1914, MSA is a global leader in the development, manufacture and supply of safety products that protect people's health and safety. Many MSA products typically integrate any combination of electronics, mechanical systems and advanced materials to protect users against hazardous or life-threatening situations. The company's comprehensive line of products is used by workers around the world in the fire service, oil, gas and petrochemical industry, homeland security, construction, mining and other industries, as well as the military. Principal products include self-contained breathing apparatus, gas masks, gas detection instruments, head protection, ballistic body armor, fall protection devices and thermal imaging cameras. The company also provides a broad range of consumer and contractor safety products through retail channels. These products are marketed and sold under the MSA Safety Works brand. MSA has annual sales of approximately $1 billion, manufacturing operations in the United States, Europe, Asia and Latin America, and more than 40 international locations. Additional information is available on the company's Web site at http://www.msanet.com.


'/>"/>
SOURCE MSA
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Unilens Vision Inc. Declares Regular Quarterly Cash Dividend of U.S. $0.09 Per Share
2. Torchmark Corporation Declares Dividend
3. Mylan Declares Quarterly Preferred Stock Dividend
4. NHP Declares Quarterly Cash Dividends on Common Stock and Series B Preferred Stock
5. Infinity Property and Casualty Corporation Declares Quarterly Dividend
6. Abbott Declares 339th Consecutive Quarterly Dividend
7. Landauer, Inc. Declares Regular Cash Dividend
8. Longs Drug Stores Corporation Declares Cash Dividend on Common Shares
9. Mesa Labs Declares Quarterly Dividend
10. Cardinal Health Declares Regular Quarterly Dividend
11. NHP Declares Quarterly Cash Dividends on Common Stock and Series B Preferred Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... NC (PRWEB) , ... December 08, 2016 , ... ... Medicare and the Affordable Care Act. Dr. Botelho advocates for the mass media ... story movement gives people ongoing opportunities to share their unfortunate experiences; such a ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... that serve communities in and around the greater Phoenix metropolitan region, is announcing ... Connection. , The mission of the Homeless Youth Connection is to promote community ...
(Date:12/7/2016)... ... December 07, 2016 , ... DrugDev again demonstrated its dedication ... one of the early adopters completing EU-U.S. Privacy Shield Certification from the U.S. Department ... on both sides of the Atlantic with a mechanism to comply with EU data ...
(Date:12/7/2016)... Orleans, LA (PRWEB) , ... December 07, 2016 ... ... technique used to treat wrinkles and deep lines by smoothing and tightening the ... minimally invasive techniques out there to address facial aging with very little downtime, ...
(Date:12/7/2016)... ... 07, 2016 , ... It is vital for any lab to secure funding, ... The team at Beckman Coulter has designed Kaluza, templates with advanced analytical tools to ... to operate in a GLP (Good Laboratory Practice) fashion. , With features designed to ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... , Dec. 8, 2016 Henry Schein, Inc. (Nasdaq: ... care products and services to office-based dental, animal health and ... equity investment in Marrodent, one of Poland,s ... $32 million. This transaction was announced on August 30, 2016. ... Poland since 2014, and Marrodent marks ...
(Date:12/8/2016)... Dec 8, 2016 Research and Markets has announced ... report to their offering. ... , The report provides separate comprehensive ... , and Rest of World. Annual estimates and ... historic analysis is provided for these markets. Market data and analytics are ...
(Date:12/7/2016)... Dec. 7, 2016 "Lantus (Insulin Glargine) Biosimilar Clinical Trial & ... biosimilar version of Lantus drug in clinical pipeline. Currently 5 biosimilar version ... Japan , Kenya , Czech ... , China , Slovakia , ... 2 diabetes mellitus. The patent on Lantus expired in 2014. Lantus ...
Breaking Medicine Technology: